Table of Contents

Part 1: Dilated Cardiomyopathy

Part 2: Hypertrophic Cardiomyopathy

Part 3: Restrictive Cardiomyopathy

Part 4: Arrhythmogenic Cardiomyopathy

Part 5: LV Non-compaction

Part 6: The Athlete's Heart

 

Multimodality Imaging

EACVI Recommendations on Imaging in Dilated Cardiomyopathy

Echocardiography

Assessement of Dilated CMP by Echo - LV Function and Remodelling

Assessement of Dilated CMP by Echo - Diastolic Function and RV Function and Pressure

Echocardiography in CRT

Cardiovascular Magnetic Resonance

CMR in Dilated Cardiomyopathy

Cardiac CT

Cardiac CT in Dilated Cardiomyopathy

Nuclear Cardiology

Dilated Cardiomyopathy:  Nuclear Imaging

 

References

  1. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.
    Akhtar MM, Lorenzini M, Pavlou M, Ochoa JP, O'Mahony C, Restrepo-Cordoba MA, Segura-Rodriguez D, Bermúdez-Jiménez F, Molina P, Cuenca S, Ader F, Larrañaga-Moreira JM, Sabater-Molina M, Garcia-Alvarez MI, Arantzamendi LG, Truszkowska G, Ortiz-Genga M, Ruiz IS, Nielson SK, Rasmussen TB, Robles Mezcua A, Alvarez-Rubio J, Eiskjaer H, Gautel M, Garcia-Pinilla JM, Ripoll-Vera T, Mogensen J, Limeres Freire J, Rodríguez-Palomares JF, Peña-Peña ML, Rangel-Sousa D, Palomino-Doza J, Arana Achaga X, Bilinska Z, Zamarreño Golvano E, Climent V, Peñalver MN, Barriales-Villa R, Charron P, Yotti R, Zorio E, Jiménez-Jáimez J, Garcia-Pavia P, Elliott PM; European Genetic Cardiomyopathies Initiative Investigators.
    JAMA Cardiol. 2021 May 12. doi: 10.1001/jamacardio.2021.1106.
  2. Cardiac MRI in cardiomyopathies.
    Lahoti N, Jabbour RJ, Ariff B, Wang BX.
    Future Cardiol. 2021 Apr 22. doi: 10.2217/fca-2020-0233.
  3. CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry.
    Guaricci AI, Masci PG, Muscogiuri G, Guglielmo M, Baggiano A, Fusini L, Lorenzoni V, Martini C, Andreini D, Pavon AG, Aquaro GD, Barison A, Todiere G, Rabbat MG, Tat E, Raineri C, Valentini A, Varga-Szemes A, Schoepf UJ, De Cecco CN, Bogaert J, Dobrovie M, Symons R, Focardi M, Gismondi A, Lozano-Torres J, Rodriguez-Palomares JF, Lanzillo C, Di Roma M, Moro C, Di Giovine G, Margonato D, De Lazzari M, Perazzolo Marra M, Nese A, Casavecchia G, Gravina M, Marzo F, Carigi S, Pica S, Lombardi M, Censi S, Squeri A, Palumbo A, Gaibazzi N, Camastra G, Sbarbati S, Pedrotti P, Masi A, Carrabba N, Pradella S, Timpani M, Cicala G, Presicci C, Puglisi S, Sverzellati N, Santobuono VE, Pepi M, Schwitter J, Pontone G.
    Europace. 2021 Apr 1:euaa401. doi: 10.1093/europace/euaa401.
  4. The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization. 
    Artico J, Merlo M, Asher C, Cannatà A, Masci PG, De Lazzari M, Pica S, De Angelis G, Porcari A, Vitrella G, De Luca A, Belgrano M, Pagnan L, Chiribiri A, Marra MP, Sinagra G, Nucifora G, Lombardi M, Carr-White G.
    Int J Cardiol. 2021 May 15;331:131-137. doi: 10.1016/j.ijcard.2021.01.067. Epub 2021 Feb 2.
  5. Myocardial Substrate Characterization by CMR T1 Mapping in Patients With NICM and No LGE Undergoing Catheter Ablation of VT.
    Muser D, Nucifora G, Castro SA, Enriquez A, Chahal CAA, Magnani S, Kumareswaran R, Arkles J, Supple G, Schaller R, Hyman M, Dixit S, Lin D, Zado ES, Tschabrunn C, Callans DJ, Nazarian S, Frankel DS, Marchlinski FE, Santangeli P.
    JACC Clin Electrophysiol. 2021 Jan 20:S2405-500X(20)30983-X. doi: 10.1016/j.jacep.2020.10.002.
  6. Who Gets Better With Dilated Cardiomyopathy?: The Evolving Role of Cardiac Magnetic Resonance Imaging.
    Wilcox JE, Fang JC.
    Circ Heart Fail. 2021 Jan;14(1):e008174. doi: 10.1161/CIRCHEARTFAILURE.120.008174. Epub 2021 Jan 19.
  7. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis Registry.
    Mizia-Stec K, Charron P, Gimeno Blanes JR, Elliott P, Kaski JP, Maggioni AP, Tavazzi L, Tendera M, Felix SB, Dominguez F, Ojrzynska N, Losi MA, Limongelli G, Barriales-Villa R, Seferovic PM, Biagini E, Wybraniec M, Laroche C, Caforio ALP; EORP Cardiomyopathy Registry Investigators.
    Eur Heart J Cardiovasc Imaging. 2021 Jan 8:jeaa329. doi: 10.1093/ehjci/jeaa329.
  8. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.
    Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, Friedrich MG, Klingel K, Lehtonen J, Moslehi JJ, Pedrotti P, Rimoldi OE, Schultheiss HP, Tschöpe C, Cooper LT Jr, Camici PG.
    Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.
  9. Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences.
    Verdonschot JAJ, Merlo M, Dominguez F, Wang P, Henkens MTHM, Adriaens ME, Hazebroek MR, Masè M, Escobar LE, Cobas-Paz R, Derks KWJ, van den Wijngaard A, Krapels IPC, Brunner HG, Sinagra G, Garcia-Pavia P, Heymans SRB.
    Eur Heart J. 2021 Jan 7;42(2):162-174. doi: 10.1093/eurheartj/ehaa841.
  10. Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy.
    Liu T, Gao Y, Wang H, Zhou Z, Wang R, Chang SS, Liu Y, Sun Y, Rui H, Yang G, Firmin D, Dong J, Xu L.
    Heart. 2020 Nov 2:heartjnl-2020-317949. doi: 10.1136/heartjnl-2020-317949.
  11. Prognostic value of multiple cardiac magnetic resonance imaging parameters in patients with idiopathic dilated cardiomyopathy.
    Fu H, Wen L, Xu H, Liu H, Xu R, Xie L, Sun R, Zhang K, Zhang L, Yang Z, Guo Y.
    Int J Cardiol. 2021 Feb 15;325:89-95. doi: 10.1016/j.ijcard.2020.09.079. Epub 2020 Oct 7.
  12. Association Between Left Ventricular Mechanical Deformation and Myocardial Fibrosis in Nonischemic Cardiomyopathy.
    Csecs I, Pashakhanloo F, Paskavitz A, Jang J, Al-Otaibi T, Neisius U, Manning WJ, Nezafat R.
    J Am Heart Assoc. 2020 Oct 20;9(19):e016797. doi: 10.1161/JAHA.120.016797. Epub 2020 Oct 2.
  13. Machine Learning Outcome Prediction in Dilated Cardiomyopathy Using Regional Left Ventricular Multiparametric Strain.
    MacGregor RM, Guo A, Masood MF, Cupps BP, Ewald GA, Pasque MK, Foraker R.
    Ann Biomed Eng. 2021 Feb;49(2):922-932. doi: 10.1007/s10439-020-02639-1. Epub 2020 Oct 1.
  14. Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology.
    D'Amario D, Camilli M, Migliaro S, Canonico F, Galli M, Arcudi A, Montone RA, Borovac JA, Crea F, Savarese G.
    Curr Cardiol Rep. 2020 Aug 8;22(10):102. doi: 10.1007/s11886-020-01377-z.
  15. Multi-Modality Imaging in Dilated Cardiomyopathy: With a Focus on the Role of Cardiac Magnetic Resonance.
    Mitropoulou P, Georgiopoulos G, Figliozzi S, Klettas D, Nicoli F, Masci PG.
    Front Cardiovasc Med. 2020 Jul 2;7:97. doi: 10.3389/fcvm.2020.00097. eCollection 2020.
  16. Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy.
    Rayner JJ, Abdesselam I, d'Arcy J, Myerson SG, Neubauer S, Watkins H, Ferreira VM, Rider OJ.
    Cardiovasc Diagn Ther. 2020 Jun;10(3):559-567. doi: 10.21037/cdt-19-587.
  17. Prognostic value of left ventricular remodelling index in idiopathic dilated cardiomyopathy.
    Xu Y, Lin J, Liang Y, Wan K, Li W, Wang J, Zhu Y, Mui D, Wang L, Li Y, Cheng W, Sun J, Zhang Q, Han Y, Chen Y.
    Eur Heart J Cardiovasc Imaging. 2020 Jul 13:jeaa144. doi: 10.1093/ehjci/jeaa144.
  18. T1 Mapping Tissue Heterogeneity Provides Improved Risk Stratification for ICDs Without Needing Gadolinium in Patients With Dilated Cardiomyopathy.
    Nakamori S, Ngo LH, Rodriguez J, Neisius U, Manning WJ, Nezafat R.
    JACC Cardiovasc Imaging. 2020 Sep;13(9):1917-1930. doi: 10.1016/j.jcmg.2020.03.014. Epub 2020 Jul 9.
  19. Parameters of left ventricular systolic and diastolic dyssynchrony on radionuclide imaging to improve cardiac resynchronization therapy in heart failure patients with dilated cardiomyopathy.
    Sreenivasan J, Jain D.
    J Nucl Cardiol. 2020 May 26. doi: 10.1007/s12350-020-02202-4.
  20. Identification of genetic variants linked with DCM using cardiac MRI.
    Huynh K.
    Nat Rev Cardiol. 2020 Jul;17(7):385. doi: 10.1038/s41569-020-0397-5.
  21. Analysis of cardiac magnetic resonance imaging in 36,000 individuals yields genetic insights into dilated cardiomyopathy.
    Pirruccello JP, Bick A, Wang M, Chaffin M, Friedman S, Yao J, Guo X, Venkatesh BA, Taylor KD, Post WS, Rich S, Lima JAC, Rotter JI, Philippakis A, Lubitz SA, Ellinor PT, Khera AV, Kathiresan S, Aragam KG.
    Nat Commun. 2020 May 7;11(1):2254. doi: 10.1038/s41467-020-15823-7.
  22. Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
    Smith ED, Lakdawala NK, Papoutsidakis N, Aubert G, Mazzanti A, McCanta AC, Agarwal PP, Arscott P, Dellefave-Castillo LM, Vorovich EE, Nutakki K, Wilsbacher LD, Priori SG, Jacoby DL, McNally EM, Helms AS.
    Circulation. 2020 Jun 9;141(23):1872-1884. doi: 10.1161/CIRCULATIONAHA.119.044934. Epub 2020 May 6.
  23. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies.
    Piriou N, Marteau L, Kyndt F, Serfaty JM, Toquet C, Le Gloan L, Warin-Fresse K, Guijarro D, Le Tourneau T, Conan E, Thollet A, Probst V, Trochu JN.
    ESC Heart Fail. 2020 Aug;7(4):1520-1533. doi: 10.1002/ehf2.12686. Epub 2020 May 1.
  24. Moving Toward Improved Risk Stratification in Patients With Dilated Cardiomyopathy.
    Markman TM, Nazarian S.
    Circ Cardiovasc Imaging. 2020 Apr;13(4):e010629. doi: 10.1161/CIRCIMAGING.120.010629. Epub 2020 Apr 21.
  25. Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group.
    Alba AC, Gaztañaga J, Foroutan F, Thavendiranathan P, Merlo M, Alonso-Rodriguez D, Vallejo-García V, Vidal-Perez R, Corros-Vicente C, Barreiro-Pérez M, Pazos-López P, Perez-David E, Dykstra S, Flewitt J, Pérez-Rivera JÁ, Vazquez-Caamaño M, Katz SD, Sinagra G, Køber L, Poole J, Ross H, Farkouh ME, White JA.
    Circ Cardiovasc Imaging. 2020 Apr;13(4):e010105. doi: 10.1161/CIRCIMAGING.119.010105. Epub 2020 Apr 21.
  26. Predicting Sudden Death in Dilated Cardiomyopathy: The Potential Power of Magnetic Resonance Imaging as a Critical Tool.
    Dorian P, Yan AT, Connelly KA.
    Can J Cardiol. 2020 Jul;36(7):1006-1008. doi: 10.1016/j.cjca.2019.12.027. Epub 2019 Dec 31.
  27. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy.
    Finocchiaro G, Merlo M, Sheikh N, De Angelis G, Papadakis M, Olivotto I, Rapezzi C, Carr-White G, Sharma S, Mestroni L, Sinagra G.
    Eur J Heart Fail. 2020 Jul;22(7):1097-1107. doi: 10.1002/ejhf.1815. Epub 2020 Apr 3.
  28. Emerging Techniques for Risk Stratification in Nonischemic Dilated Cardiomyopathy: JACC Review Topic of the Week.
    Marrow BA, Cook SA, Prasad SK, McCann GP.
    J Am Coll Cardiol. 2020 Mar 17;75(10):1196-1207. doi: 10.1016/j.jacc.2019.12.058.
  29. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy.
    Cipriani A, Bauce B, De Lazzari M, Rigato I, Bariani R, Meneghin S, Pilichou K, Motta R, Aliberti C, Thiene G, McKenna WJ, Zorzi A, Iliceto S, Basso C, Perazzolo Marra M, Corrado D.
    J Am Heart Assoc. 2020 Mar 3;9(5):e014628. doi: 10.1161/JAHA.119.014628. Epub 2020 Mar 2.
  30. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction.
    Cannatà A, De Angelis G, Boscutti A, Normand C, Artico J, Gentile P, Zecchin M, Heymans S, Merlo M, Sinagra G.
    Heart. 2020 May;106(9):656-664. doi: 10.1136/heartjnl-2019-315942. Epub 2020 Jan 21.
  31. Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.
    Aung N, Doimo S, Ricci F, Sanghvi MM, Pedrosa C, Woodbridge SP, Al-Balah A, Zemrak F, Khanji MY, Munroe PB, Naci H, Petersen SE.
    Circ Cardiovasc Imaging. 2020 Jan;13(1):e009712. doi: 10.1161/CIRCIMAGING.119.009712. Epub 2020 Jan 21.
  32. Exercise is Associated With Impaired Left Ventricular Systolic Function in Patients With Lamin A/C Genotype.
    Skjølsvik ET, Hasselberg NE, Dejgaard LA, Lie ØH, Andersen K, Holm T, Edvardsen T, Haugaa KH.
    J Am Heart Assoc. 2020 Jan 21;9(2):e012937. doi: 10.1161/JAHA.119.012937. Epub 2020 Jan 20.
  33. The Value of Strain in Familial Dilated Cardiomyopathy Screening.
    Prasad SK, Tayal U.
    JACC Cardiovasc Imaging. 2020 Feb;13(2 Pt 2):559-561. doi: 10.1016/j.jcmg.2019.09.004. Epub 2019 Dec 18.
  34. Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement?
    Barison A, Aquaro GD, Emdin M.
    JACC Cardiovasc Imaging. 2019 Dec;12(12):2586-2587. doi: 10.1016/j.jcmg.2019.08.029.
  35. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy.
    Cannatà A, Fabris E, Merlo M, Artico J, Gentile P, Pio Loco C, Ballaben A, Ramani F, Barbati G, Sinagra G.
    Can J Cardiol. 2020 Jan;36(1):37-44. doi: 10.1016/j.cjca.2019.05.031. Epub 2019 May 30.
  36. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging.
    Donal E, Delgado V, Bucciarelli-Ducci C, Galli E, Haugaa KH, Charron P, Voigt JU, Cardim N, Masci PG, Galderisi M, Gaemperli O, Gimelli A, Pinto YM, Lancellotti P, Habib G, Elliott P, Edvardsen T, Cosyns B, Popescu BA; 2016–18 EACVI Scientific Documents Committee.
    Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1075-1093. doi: 10.1093/ehjci/jez178.